People in the News: Paul Billings, Stephen Jones, Thomas Kean, Allan Bombard, Ross Levine, More | GenomeWeb

Paul Billings has joined Omicia as chief medical officer and will serve on the company's scientific advisory board. Billings was previously chief medical officer at Thermo Fisher's Life Technologies. Before that, he was founding and acting director and CSO at the Genomic Medicine Institute at El Camino Hospital. He was also previously President, CEO, and director of CELLective Dx, as well as senior vice president and senior geneticist at Laboratory Corporation of America. He is currently a director at Trovagene and CollabRx.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.